Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Guanwu Wang, Lara Rosaline Heij, Dong Liu, Edgar Dahl, Sven Arke LANG, Tom Florian Ulmer, Tom LUEDDE, Ulf Peter Neumann & Jan Bednarsch. (2022) The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review. Cancers 14:23, pages 5969.
Crossref
Crossref
Patrick Terrematte, Dhiego Andrade, Josivan Justino, Beatriz Stransky, Daniel de Araújo & Adrião Dória Neto. (2022) A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients. Cancers 14:9, pages 2111.
Crossref
Crossref
Sandra Pavicevic, Sophie Reichelt, Deniz Uluk, Isabella Lurje, Cornelius Engelmann, Dominik P. Modest, Uwe Pelzer, Felix Krenzien, Nathanael Raschzok, Christian Benzing, Igor M. Sauer, Sebastian Stintzing, Frank Tacke, Wenzel Schöning, Moritz Schmelzle, Johann Pratschke & Georg Lurje. (2022) Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers 14:4, pages 1026.
Crossref
Crossref
Ali Reza Safarpour, Hassan Askari, Farshid Ejtehadi, Asaad Azarnezhad, Ehsan Raeis-Abdollahi, Amir Tajbakhsh, Mohammad Foad Abazari, Firoozeh Tarkesh, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Kamran Bagheri Lankarani & Fardad Ejtehadi. (2021) Cholangiocarcinoma and liver transplantation: What we know so far?. World Journal of Gastrointestinal Pathophysiology 12:5, pages 84-105.
Crossref
Crossref
Nizar M. Mhaidat, Haneen Amawi & Karem H. Alzoubi. (2021) Correlation Between BCL2 and Mcl1 Single Nucleotide Polymorphisms and Chemotherapy Response in Jordanian Patients with Colorectal Cancer. Current Pharmaceutical Biotechnology 22:5, pages 646-653.
Crossref
Crossref
Nicola Personeni, Ana Lleo, Tiziana Pressiani, Francesca Colapietro, Mark Robert Openshaw, Chara Stavraka, Athanasios Pouptsis, David James Pinato & Lorenza Rimassa. (2020) Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options. Cancers 12:11, pages 3370.
Crossref
Crossref
Alessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, Giorgio Frega, Andrea Palloni, Valeria Relli, Massimiliano Salati, Elisabetta Fenocchio, Annamaria Massa, Massimo Aglietta & Giovanni Brandi. (2020) Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures. Cancers 12:11, pages 3256.
Crossref
Crossref
Ines Malenica, Matteo Donadon & Ana Lleo. (2020) Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine. Cancers 12:8, pages 2190.
Crossref
Crossref
Chiara Braconi, Stephanie Roessler, Beata Kruk, Frank Lammert, Marcin Krawczyk & Jesper B Andersen. (2019) Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?. Liver International 39:S1, pages 32-42.
Crossref
Crossref
Benjamin Juntermanns, Gernot Maximilian Kaiser, Lena Orth, Henning Reis, Derar Jaradat, Svenja Sydor, Matthias Buechter, Stefan Kasper, Zoltan Mathé, Georgios Charalambos Sotiropoulos, Hideo Andreas Baba, Ali Canbay, Andreas Paul & Christian Dominik Fingas. (2018) Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma. European Journal of Medical Research 23:1.
Crossref
Crossref
B. Juntermanns, G. M. Kaiser, S. Itani Gutierrez, M. Heuer, M. Buechter, A. Kahraman, H. Reis, S. Kasper, A. Paul & C. D. Fingas. (2018) CA19-9 beim intrahepatischen CholangiokarzinomCA19-9 in intrahepatic cholangiocarcinoma. Der Chirurg 89:6, pages 466-471.
Crossref
Crossref
Zhongqiang Yao, Binhui Yang, Zhongqiu Liu, Wei Li, Qihua He & Xingchun Peng. (2017) Genetic polymorphisms of Bcl-2 promoter in cancer susceptibility and prognosis: a meta-analysis. Oncotarget 8:15, pages 25270-25278.
Crossref
Crossref
Svenja Sydor, Sami Jafoui, Lena Wingerter, Sandra Swoboda, Joachim C Mertens, Guido Gerken, Ali Canbay, Andreas Paul & Christian D Fingas. (2017) Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells. World Journal of Gastroenterology 23:22, pages 4007.
Crossref
Crossref
Yu. O. Zharikov, Yu. A. Kovalenko & A. V. Czhao. (2016) Biomolecular prognostic factors in Klatskin tumor. Khirurgiya. Zhurnal im. N.I. Pirogova:5, pages 82.
Crossref
Crossref
Benjamin Juntermanns, Svenja Sydor, Gernot M. Kaiser, Derar Jaradat, Joachim C. Mertens, Georgios C. Sotiropoulos, Sandra Swoboda, Jan P. Neuhaus, Wei Meng, Zoltan Mathé, Hideo A. Baba, Ali Canbay, Andreas Paul & Christian D. Fingas. (2015) Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma. Liver International 35:11, pages 2448-2457.
Crossref
Crossref
Xiao Zhang, Wenhao Weng, Wen Xu, Yulan Wang, Wenjun Yu, Xun Tang, Lifang Ma, Qiuhui Pan, Jiayi Wang & Fenyong Sun. (2014) Role of Bcl-2 -938 C>A polymorphism in susceptibility and prognosis of cancer: a meta-analysis. Scientific Reports 4:1.
Crossref
Crossref
Denghua Yao, Vamsi Krishna Kunam & Xiao Li. (2013) A review of the clinical diagnosis and therapy of cholangiocarcinoma. Journal of International Medical Research 42:1, pages 3-16.
Crossref
Crossref
Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Svenja Sydor, Steven F. Bronk, John D. Christensen, Sumera H. Rizvi, Ali Canbay, Jürgen W. Treckmann, Andreas Paul, Alphonse E. Sirica & Gregory J. Gores. (2013) Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma. Hepatology 58:4, pages 1362-1374.
Crossref
Crossref
Benjamin Juntermanns, Georgios Charalambos Sotiropoulos, Sonia Radunz, Henning Reis, Matthias Heuer, Hideo Andreas Baba, Ali Canbay, Martin Schuler, Guido Gerken, Andreas Paul & Gernot Maximilian Kaiser. (2012) Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma. Annals of Surgical Oncology 20:1, pages 277-284.
Crossref
Crossref
Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Steven F. Bronk, Alphonse E. Sirica & Gregory J. Gores. (2011)
Targeting
PDGFR
‐β in Cholangiocarcinoma
. Liver International 32:3, pages 400-409.
Crossref
Crossref
Alisan Kahraman, Christian D. Fingas, Wing‐Kin Syn, Guido Gerken & Ali Canbay. (2011)
Role of stress‐induced
NKG2D
ligands in liver diseases
. Liver International 32:3, pages 370-382.
Crossref
Crossref
Hyeon Kang KohHae Jin ParkKyubo KimEui Kyu ChieHye Sook MinSung W. Ha. (2012) Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery. Radiation Oncology Journal 30:4, pages 197.
Crossref
Crossref
Christian D. Fingas, Steven F. Bronk, Nathan W. Werneburg, Justin L. Mott, Maria E. Guicciardi, Sophie C. Cazanave, Joachim C. Mertens, Alphonse E. Sirica & Gregory J. Gores. (2011) Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells. Hepatology 54:6, pages 2076-2088.
Crossref
Crossref
Stefanie Klenke & Winfried Siffert. (2011) SNPs in genes encoding G proteins in pharmacogenetics. Pharmacogenomics 12:5, pages 633-654.
Crossref
Crossref
Christopher A. Wadsworth, Peter H. Dixon, Jason H. Wong, Michael H. Chapman, Siobhan C. McKay, Amar Sharif, Duncan R. Spalding, Stephen P. Pereira, Howard C. Thomas, Simon D. Taylor-Robinson, John Whittaker, Catherine Williamson & Shahid A. Khan. (2011) Genetic Factors in the Pathogenesis of Cholangiocarcinoma. Digestive Diseases 29:1, pages 93-97.
Crossref
Crossref